SCHEMBL10972811

SCHEMBL10972811

Nc1ncnc2ccc(NC(=O)C3CCCCC3)cc12

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 14/20 0.73
EGFR P00533 2/20 0.61
PTPN1 P18031 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15587571 0.85 MAP4K4 (1.00) MAP4K4
SCHEMBL14537165 0.83 MAP4K4 (0.81) MAP4K4
SCHEMBL23758885 0.82 EGFR (0.53) MAP4K4EGFRPTPN1
SCHEMBL6092610 0.81 ULK1 (0.61) MAP4K4
SCHEMBL15587548 0.80 MAP4K4 (1.00) MAP4K4
SCHEMBL10965800 0.79 MAP4K4 (0.57) MAP4K4
SCHEMBL6093993 0.78 MAP4K4 (0.53) MAP4K4
SCHEMBL15587447 0.78 MAP4K4 (1.00) MAP4K4
SCHEMBL10967231 0.78 EGFR (0.61) MAP4K4EGFRPTPN1
SCHEMBL11099106 0.76 EGFR (0.59) MAP4K4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4543356-A Quinazoline derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-09-24 US disclosed
EP-0030156-B1 QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-03-21 EP disclosed
US-4429126-A ANTIASTHMA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-01-31 US disclosed
US-4377580-A ANTIALLERGENIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-03-22 US disclosed
EP-0030156-A1 Quinazoline derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-10 EP disclosed